Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy? - PubMed (original) (raw)

Comment

Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy?

F Grodstein. Am J Epidemiol. 1996.

No abstract available

PubMed Disclaimer

Comment on

• Prior to use of estrogen replacement therapy, are users healthier than nonusers?
  Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Matthews KA, et al. Am J Epidemiol. 1996 May 15;143(10):971-8. doi: 10.1093/oxfordjournals.aje.a008678. Am J Epidemiol. 1996. PMID: 8629615

Similar articles

• Women's health. The vanishing promises of hormone replacement.
  Enserink M. Enserink M. Science. 2002 Jul 19;297(5580):325-6. doi: 10.1126/science.297.5580.325. Science. 2002. PMID: 12130763 No abstract available.
• Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
  Birkhäuser MH, Panay N, Archer DF, Barlow D, Burger H, Gambacciani M, Goldstein S, Pinkerton JA, Sturdee DW. Birkhäuser MH, et al. Climacteric. 2008 Apr;11(2):108-23. doi: 10.1080/13697130801983921. Climacteric. 2008. PMID: 18365854 No abstract available.
• Cardiovascular disease and hormone replacement therapy: a review.
  Ayalon D, Pines A. Ayalon D, et al. Isr J Med Sci. 1993 Oct;29(10):660-3. Isr J Med Sci. 1993. PMID: 8244671 Review. No abstract available.
• Hormone replacement therapy. Should be used selectively.
  Stevenson JC, Baum M. Stevenson JC, et al. BMJ. 1994 Jul 16;309(6948):191-2. BMJ. 1994. PMID: 8044103 Free PMC article. No abstract available.
• Primary prevention of cardiovascular disease with HRT.
  Maclaran K, Stevenson JC. Maclaran K, et al. Womens Health (Lond). 2012 Jan;8(1):63-74. doi: 10.2217/whe.11.87. Womens Health (Lond). 2012. PMID: 22171776 Review.

Cited by

• Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
  Ramsden CE, Zamora D, Majchrzak-Hong S, Faurot KR, Broste SK, Frantz RP, Davis JM, Ringel A, Suchindran CM, Hibbeln JR. Ramsden CE, et al. BMJ. 2016 Apr 12;353:i1246. doi: 10.1136/bmj.i1246. BMJ. 2016. PMID: 27071971 Free PMC article. Review.
• All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts.
  Ramsden CE, Hibbeln JR, Majchrzak-Hong SF. Ramsden CE, et al. World Rev Nutr Diet. 2011;102:30-43. doi: 10.1159/000327789. Epub 2011 Aug 5. World Rev Nutr Diet. 2011. PMID: 21865817 Free PMC article. No abstract available.
• Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
  Lambert LJ, Straton JA, Knuiman MW, Bartholomew HC. Lambert LJ, et al. J Epidemiol Community Health. 2003 Apr;57(4):294-300. doi: 10.1136/jech.57.4.294. J Epidemiol Community Health. 2003. PMID: 12646547 Free PMC article.
• Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations.
  Panico S, Galasso R, Celentano E, Ciardullo AV, Frova L, Capocaccia R, Trevisan M, Berrino F. Panico S, et al. Am J Public Health. 2000 Sep;90(9):1397-402. doi: 10.2105/ajph.90.9.1397. Am J Public Health. 2000. PMID: 10983196 Free PMC article.
• Low use of long-term hormone replacement therapy in Denmark.
  Olesen C, Steffensen FH, Sørensen HT, Nielsen GL, Olsen J, Bergman U. Olesen C, et al. Br J Clin Pharmacol. 1999 Mar;47(3):323-8. doi: 10.1046/j.1365-2125.1999.00879.x. Br J Clin Pharmacol. 1999. PMID: 10215757 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information